查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1828883

放射性药物市场分析及预测（至 2034 年）：依类型、产品、应用、最终使用者、技术、形式、服务、模式及阶段

Radiopharmaceuticals Market Analysis and Forecast to 2034: Type, Product, Application, End User, Technology, Form, Services, Mode, Stage
出版日期: | 出版商: Global Insight Services | 英文 325 Pages | 商品交期: 3-5个工作天内

价格
简介目录

放射性药物市场预计将从2024年的184亿美元增加到2034年的720亿美元，复合年增长率约为14.6%。放射性药物市场包括用于核子医学诊断和治疗的化合物，以及放射性同位素和药物的组合。这些药物针对特定器官、组织和细胞受体，从而实现癌症等疾病的精准成像和治疗。医学影像技术的进步、慢性病的增加以及放射性标记技术的创新正在推动市场发展，并刺激诊断和治疗应用的成长。

在核子医学进步和标靶治疗需求不断增长的推动下，放射性药物市场持续强劲扩张。诊断领域处于领先地位，这得益于 PET 示踪剂的主导地位，其对肿瘤学和神经病学应用尤为重要。紧随其后的是 SPECT 示踪剂，反映了它们在心臟病学和骨骼影像领域的持续相关性。在治疗领域，放射性标记单株抗体因其针对癌细胞的特异性而受到关注。胜肽受体放射性核种治疗 (PRRT) 也正在成为一种有前景的神经内分泌肿瘤治疗方法。市场正在见证向治疗诊断的转变，它结合了影像和治疗能力，以增强个人化医疗方法。新型放射性同位素的开发和放射化学的进步进一步推动了市场成长。製药公司和研究机构之间的策略联盟与合作正在推动创新并加速临床试验。预计对放射性药物研发和监管支持的不断增加将保持市场势头。

市场区隔
类型 诊断放射性药物、治疗放射性药物
产品 Technetium-99m、碘-131、氟脱氧葡萄糖 (FDG)、镓-68、镏-177、钇-90、镭-223、钐-153、锶-89
应用领域 肿瘤科、心臟科、神经科、内分泌科、胃肠科、肾臟科、骨科
最终用户 医院、诊断中心、门诊手术中心、学术和研究机构、製药和生物技术公司
科技 迴旋加速器、核子反应炉、线性加速器
形状 液体、固体、气体
服务 放射性同位素生产、放射性药物生产、品管和测试、法规遵循、物流和分销
形式 内部、外包
阶段 临床前、临床、商业化

市场概述

放射性药物市场的特征是市占率分布动态变化、定价策略具有竞争力、新产品上市激增。主要企业正专注于创新技术以加强产品系列。市场正在见证向精准医疗的转变，推动对标靶放射性药物治疗的需求。北美持续占据主导地位，大力投资研发。受医疗成本上升和技术进步的推动，欧洲和亚太地区也在经历显着成长。竞争性基准基准化分析揭示了策略联盟和合併的突出格局。公司正在利用伙伴关係关係企业发展并加强其产品供应。监管影响起着关键作用，严格的指导方针影响市场进入和合规性。美国FDA 和欧洲药品管理局是塑造市场动态的主要监管机构。随着市场的发展，专注于安全性和有效性的技术创新继续推动成长，为相关人员提供有利可图的机会。

主要趋势和驱动因素：

在核子医学和个人化医疗的推动下，放射性药物市场正经历强劲成长。主要趋势包括放射性药物在癌症诊断和治疗中的应用日益广泛，这导致人们对精准医疗的关注度不断提升。针对特定癌症类型的新型放射性药物的开发正在提高治疗效果和患者预后。此外，慢性病的增加和人口老化正在推动对诊断影像的需求。混合成像系统等技术创新进一步推动了市场扩张。支持性的监管机构和优惠的报销政策正在鼓励对放射性药物研发的投资。製药公司和研究机构之间的策略联盟也在刺激创新。在医疗基础设施不断发展的新兴市场中，也蕴藏大量机会。专注于扩展产品系列和地理覆盖范围的公司将能够充分利用这些趋势。在持续的科学进步和日益增长的医疗保健需求的推动下，放射性药物市场预计将持续成长。

限制与挑战：

放射性药物市场面临许多重大限制与挑战。其中一项关键挑战是严格的监管环境。监管机构实施严格的测试和核准流程，这可能会延迟新产品的推出。这给中小企业设置了进入壁垒，并抑制了创新。另一项挑战是放射性药物的生产成本高。生产放射性药物需要专门的设施和设备，这增加了营运成本并限制了市场扩张。此外，许多放射性药物的半衰期较短，需要强大的供应链来确保及时供应，这进一步增加了物流的复杂性。市场也面临熟练专业人员短缺的问题。核子医学专业知识对于放射性药物的安全处理和应用至关重要，但合格人员数量有限。此外，公众对辐射的认知和恐惧也构成了障碍。对安全的误解导致人们不愿意接受放射性药物治疗，影响了市场成长。

关键人物

先进加速器应用、Blue Earth Diagnostics、ITM Isotope Technologies Munich、Lantheus Medical Imaging、Jubilant Radiopharma、Curium、Telix Pharmaceuticals、Bayer Radiopharma、NorthStar Medical Radioisotopes、Eckert &Ziegler、Sofie Biosciences、Cardinal Health Radiopharmacy、Isoiadia, Molec

目录

第 1 章 放射性药物市场概述

  • 调查目的
  • 放射性药物市场定义与研究范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章：放射性药物市场展望

  • 放射性药物市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章放射性药物市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章：放射性药物市场规模

  • 放射性药物市场规模（以价值计算）
  • 放射性药物市场规模（按体积）

第七章放射性药物市场（按类型）

  • 市场概况
  • 诊断放射性药物
  • 治疗性放射性药物
  • 其他的

第 8 章：放射性药物市场（按产品）

  • 市场概况
  • Technetium-99m
  • 碘-131
  • 氟脱氧葡萄糖（FDG）
  • 镓-68
  • 镏-177
  • 钇-90
  • 镭-223
  • 钐-153
  • 锶-89
  • 其他的

第九章放射性药物市场（依应用）

  • 市场概况
  • 肿瘤学
  • 循环系统
  • 神经病学
  • 内分泌学
  • 胃肠病学
  • 肾臟病学
  • 整形外科
  • 其他的

第 10 章 放射性药物市场（依最终使用者）

  • 市场概况
  • 医院
  • 诊断中心
  • 门诊手术中心
  • 学术和研究机构
  • 製药和生物技术公司
  • 其他的

第11章放射性药物市场（依技术）

  • 市场概况
  • 迴旋加速器
  • 核子反应炉
  • 线性加速器
  • 其他的

第 12 章：放射性药物市场（依形式）

  • 市场概况
  • 液体
  • 固体的
  • 气体
  • 其他的

第十三章放射性药物市场（按服务）

  • 市场概况
  • 放射性同位素生产
  • 放射性药物製造
  • 品管和测试
  • 监理合规
  • 物流/配送
  • 其他的

第 14 章 放射性药物市场（按模式）

  • 市场概况
  • 内部
  • 外包
  • 其他的

第 15 章放射性药物市场分阶段

  • 市场概况
  • 临床前
  • 临床
  • 商业
  • 其他的

第十六章放射性药物市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市占率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章：公司简介

  • Advanced Accelerator Applications
  • Blue Earth Diagnostics
  • ITM Isotope Technologies Munich
  • Lantheus Medical Imaging
  • Jubilant Radiopharma
  • Curium
  • Telix Pharmaceuticals
  • Bayer Radiopharma
  • NorthStar Medical Radioisotopes
  • Eckert & Ziegler
  • Sofie Biosciences
  • Cardinal Health Radiopharmacy
  • Isotopia Molecular Imaging
  • Radiomedix
  • ImaginAb
简介目录
Product Code: GIS34195

Radiopharmaceuticals Market is anticipated to expand from $18.4 billion in 2024 to $72 billion by 2034, growing at a CAGR of approximately 14.6%. The Radiopharmaceuticals Market encompasses compounds used in nuclear medicine for diagnosis and therapy, integrating radioactive isotopes with pharmaceutical agents. These agents target specific organs, tissues, or cellular receptors, enabling precise imaging and treatment of diseases like cancer. The market is driven by advancements in medical imaging, increasing prevalence of chronic diseases, and innovations in radiolabeling techniques, fostering growth in diagnostic and therapeutic applications.

The Radiopharmaceuticals Market is experiencing robust expansion, fueled by advancements in nuclear medicine and increasing demand for targeted therapies. The diagnostic segment leads in performance, particularly with the dominance of PET tracers, which are essential in oncology and neurology applications. SPECT tracers follow, reflecting their continued relevance in cardiology and bone imaging. In the therapeutic segment, radiolabeled monoclonal antibodies are gaining momentum, driven by their specificity in targeting cancer cells. Peptide receptor radionuclide therapy (PRRT) is also emerging as a promising treatment for neuroendocrine tumors. The market is witnessing a shift towards theranostics, combining diagnostic imaging and therapeutic capabilities, enhancing personalized medicine approaches. The development of novel radioisotopes and advancements in radiochemistry are further propelling market growth. Strategic partnerships and collaborations among pharmaceutical companies and research institutions are fostering innovation and accelerating clinical trials. Increasing investments in R&D and regulatory support for radiopharmaceuticals are expected to sustain market momentum.

Market Segmentation
TypeDiagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals
ProductTechnetium-99m, Iodine-131, Fluorodeoxyglucose (FDG), Gallium-68, Lutetium-177, Yttrium-90, Radium-223, Samarium-153, Strontium-89
ApplicationOncology, Cardiology, Neurology, Endocrinology, Gastroenterology, Nephrology, Orthopedics
End UserHospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies
TechnologyCyclotron, Nuclear Reactor, Linear Accelerator
FormLiquid, Solid, Gaseous
ServicesRadioisotope Production, Radiopharmaceutical Manufacturing, Quality Control and Testing, Regulatory Compliance, Logistics and Distribution
ModeIn-house, Outsourced
StagePreclinical, Clinical, Commercial

Market Snapshot:

The radiopharmaceuticals market is characterized by dynamic market share distribution, competitive pricing strategies, and a surge in new product launches. Key players are focusing on innovative technologies to enhance their product portfolios. The market is witnessing a shift towards precision medicine, driving demand for targeted radiopharmaceutical therapies. North America remains a dominant player, with substantial investments in research and development. Europe and Asia-Pacific are also experiencing significant growth, propelled by increasing healthcare expenditure and technological advancements. Competition benchmarking reveals a landscape marked by strategic collaborations and mergers. Companies are leveraging partnerships to expand their global footprint and enhance product offerings. Regulatory influences play a pivotal role, with stringent guidelines impacting market entry and compliance. The U.S. FDA and the European Medicines Agency are key regulatory bodies shaping the market dynamics. As the market evolves, the focus on safety and efficacy continues to drive innovation, offering lucrative opportunities for stakeholders.

Geographical Overview:

The radiopharmaceuticals market is experiencing notable growth across various regions, each presenting unique opportunities. North America remains a dominant force, driven by advanced healthcare infrastructure and substantial investments in nuclear medicine. The region's focus on precision medicine and increasing prevalence of chronic diseases further bolster market expansion. Europe follows, with strong research and development initiatives and regulatory support enhancing market dynamics. The emphasis on innovative cancer therapies and diagnostics contributes to the region's growth. In Asia Pacific, the market is expanding rapidly, fueled by rising healthcare expenditures and increasing awareness of nuclear medicine's benefits. Emerging economies like China and India are pivotal in this growth trajectory. Latin America and the Middle East & Africa are emerging markets with significant potential. Latin America is witnessing increased adoption of radiopharmaceuticals, driven by improving healthcare infrastructure. Meanwhile, the Middle East & Africa are recognizing the importance of nuclear medicine in advancing healthcare outcomes, presenting lucrative opportunities for market players.

Key Trends and Drivers:

The radiopharmaceuticals market is experiencing robust growth driven by advancements in nuclear medicine and personalized healthcare. Key trends include the increasing use of radiopharmaceuticals in cancer diagnosis and treatment, where precision medicine is gaining prominence. The development of novel radiopharmaceuticals targeting specific cancer types is enhancing treatment efficacy and patient outcomes. Moreover, the rising prevalence of chronic diseases and an aging population are fueling demand for diagnostic imaging. Technological innovations, such as hybrid imaging systems, are further propelling market expansion. Regulatory support and favorable reimbursement policies are encouraging investment in radiopharmaceutical research and development. The market is also witnessing strategic collaborations between pharmaceutical companies and research institutions, fostering innovation. Opportunities abound in emerging markets, where healthcare infrastructure is improving. Companies that focus on expanding their product portfolio and geographic reach are well-positioned to capitalize on these trends. The radiopharmaceuticals market is poised for sustained growth, driven by ongoing scientific advancements and increasing healthcare demands.

Restraints and Challenges:

The radiopharmaceuticals market encounters several formidable restraints and challenges. One significant challenge is the stringent regulatory landscape. Regulatory bodies impose rigorous testing and approval processes, which can delay the introduction of new products. This creates a barrier to entry for smaller companies and stifles innovation. Another challenge is the high cost associated with radiopharmaceutical production. The need for specialized facilities and equipment increases operational expenses, limiting market expansion. Additionally, the short half-life of many radiopharmaceuticals necessitates a robust supply chain to ensure timely delivery, further complicating logistics. The market also faces a shortage of skilled professionals. Expertise in nuclear medicine is essential for the safe handling and application of radiopharmaceuticals, yet there is a limited pool of qualified personnel. Furthermore, public perception and fear of radiation pose hurdles. Misunderstandings about safety can lead to reluctance in adopting radiopharmaceutical treatments, affecting market growth.

Key Players:

Advanced Accelerator Applications, Blue Earth Diagnostics, ITM Isotope Technologies Munich, Lantheus Medical Imaging, Jubilant Radiopharma, Curium, Telix Pharmaceuticals, Bayer Radiopharma, NorthStar Medical Radioisotopes, Eckert & Ziegler, Sofie Biosciences, Cardinal Health Radiopharmacy, Isotopia Molecular Imaging, Radiomedix, ImaginAb

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Radiopharmaceuticals Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Radiopharmaceuticals Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by End User
  • 2.7 Key Highlights of the Market, by Technology
  • 2.8 Key Highlights of the Market, by Form
  • 2.9 Key Highlights of the Market, by Services
  • 2.10 Key Highlights of the Market, by Mode
  • 2.11 Key Highlights of the Market, by Stage
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by End User
  • 3.6 Market Attractiveness Analysis, by Technology
  • 3.7 Market Attractiveness Analysis, by Form
  • 3.8 Market Attractiveness Analysis, by Services
  • 3.9 Market Attractiveness Analysis, by Mode
  • 3.10 Market Attractiveness Analysis, by Stage
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Radiopharmaceuticals Market Outlook

  • 4.1 Radiopharmaceuticals Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Radiopharmaceuticals Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Radiopharmaceuticals Market Size

  • 6.1 Radiopharmaceuticals Market Size, by Value
  • 6.2 Radiopharmaceuticals Market Size, by Volume

7: Radiopharmaceuticals Market, by Type

  • 7.1 Market Overview
  • 7.2 Diagnostic Radiopharmaceuticals
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutic Radiopharmaceuticals
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Radiopharmaceuticals Market, by Product

  • 8.1 Market Overview
  • 8.2 Technetium-99m
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Iodine-131
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Fluorodeoxyglucose (FDG)
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Gallium-68
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Lutetium-177
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Yttrium-90
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Radium-223
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Samarium-153
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Strontium-89
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region
  • 8.11 Others
    • 8.11.1 Key Market Trends & Opportunity Analysis
    • 8.11.2 Market Size and Forecast, by Region

9: Radiopharmaceuticals Market, by Application

  • 9.1 Market Overview
  • 9.2 Oncology
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Cardiology
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Neurology
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Endocrinology
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Gastroenterology
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Nephrology
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Orthopedics
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region
  • 9.9 Others
    • 9.9.1 Key Market Trends & Opportunity Analysis
    • 9.9.2 Market Size and Forecast, by Region

10: Radiopharmaceuticals Market, by End User

  • 10.1 Market Overview
  • 10.2 Hospitals
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Diagnostic Centers
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Academic and Research Institutes
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Pharmaceutical and Biotechnology Companies
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Radiopharmaceuticals Market, by Technology

  • 11.1 Market Overview
  • 11.2 Cyclotron
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Nuclear Reactor
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Linear Accelerator
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Radiopharmaceuticals Market, by Form

  • 12.1 Market Overview
  • 12.2 Liquid
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Solid
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Gaseous
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Radiopharmaceuticals Market, by Services

  • 13.1 Market Overview
  • 13.2 Radioisotope Production
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Radiopharmaceutical Manufacturing
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Quality Control and Testing
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Regulatory Compliance
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Logistics and Distribution
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Others
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region

14: Radiopharmaceuticals Market, by Mode

  • 14.1 Market Overview
  • 14.2 In-house
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Outsourced
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Radiopharmaceuticals Market, by Stage

  • 15.1 Market Overview
  • 15.2 Preclinical
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Clinical
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Commercial
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Radiopharmaceuticals Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Application
    • 16.2.5 North America Market Size and Forecast, by End User
    • 16.2.6 North America Market Size and Forecast, by Technology
    • 16.2.7 North America Market Size and Forecast, by Form
    • 16.2.8 North America Market Size and Forecast, by Services
    • 16.2.9 North America Market Size and Forecast, by Mode
    • 16.2.10 North America Market Size and Forecast, by Stage
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Application
      • 16.2.9.4 United States Market Size and Forecast, by End User
      • 16.2.9.5 United States Market Size and Forecast, by Technology
      • 16.2.9.6 United States Market Size and Forecast, by Form
      • 16.2.9.7 United States Market Size and Forecast, by Services
      • 16.2.9.8 United States Market Size and Forecast, by Mode
      • 16.2.9.9 United States Market Size and Forecast, by Stage
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Application
      • 16.2.10.4 Canada Market Size and Forecast, by End User
      • 16.2.10.5 Canada Market Size and Forecast, by Technology
      • 16.2.10.6 Canada Market Size and Forecast, by Form
      • 16.2.10.7 Canada Market Size and Forecast, by Services
      • 16.2.10.8 Canada Market Size and Forecast, by Mode
      • 16.2.10.9 Canada Market Size and Forecast, by Stage
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Application
    • 16.3.5 Europe Market Size and Forecast, by End User
    • 16.3.6 Europe Market Size and Forecast, by Technology
    • 16.3.7 Europe Market Size and Forecast, by Form
    • 16.3.8 Europe Market Size and Forecast, by Services
    • 16.3.9 Europe Market Size and Forecast, by Mode
    • 16.3.10 Europe Market Size and Forecast, by Stage
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.4 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Form
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Mode
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Application
      • 16.3.10.4 Germany Market Size and Forecast, by End User
      • 16.3.10.5 Germany Market Size and Forecast, by Technology
      • 16.3.10.6 Germany Market Size and Forecast, by Form
      • 16.3.10.7 Germany Market Size and Forecast, by Services
      • 16.3.10.8 Germany Market Size and Forecast, by Mode
      • 16.3.10.9 Germany Market Size and Forecast, by Stage
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Application
      • 16.3.11.4 France Market Size and Forecast, by End User
      • 16.3.11.5 France Market Size and Forecast, by Technology
      • 16.3.11.6 France Market Size and Forecast, by Form
      • 16.3.11.7 France Market Size and Forecast, by Services
      • 16.3.11.8 France Market Size and Forecast, by Mode
      • 16.3.11.9 France Market Size and Forecast, by Stage
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Application
      • 16.3.12.4 Spain Market Size and Forecast, by End User
      • 16.3.12.5 Spain Market Size and Forecast, by Technology
      • 16.3.12.6 Spain Market Size and Forecast, by Form
      • 16.3.12.7 Spain Market Size and Forecast, by Services
      • 16.3.12.8 Spain Market Size and Forecast, by Mode
      • 16.3.12.9 Spain Market Size and Forecast, by Stage
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Application
      • 16.3.13.4 Italy Market Size and Forecast, by End User
      • 16.3.13.5 Italy Market Size and Forecast, by Technology
      • 16.3.13.6 Italy Market Size and Forecast, by Form
      • 16.3.13.7 Italy Market Size and Forecast, by Services
      • 16.3.13.8 Italy Market Size and Forecast, by Mode
      • 16.3.13.9 Italy Market Size and Forecast, by Stage
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Application
      • 16.3.14.4 Netherlands Market Size and Forecast, by End User
      • 16.3.14.5 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.6 Netherlands Market Size and Forecast, by Form
      • 16.3.14.7 Netherlands Market Size and Forecast, by Services
      • 16.3.14.8 Netherlands Market Size and Forecast, by Mode
      • 16.3.14.9 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Application
      • 16.3.15.4 Sweden Market Size and Forecast, by End User
      • 16.3.15.5 Sweden Market Size and Forecast, by Technology
      • 16.3.15.6 Sweden Market Size and Forecast, by Form
      • 16.3.15.7 Sweden Market Size and Forecast, by Services
      • 16.3.15.8 Sweden Market Size and Forecast, by Mode
      • 16.3.15.9 Sweden Market Size and Forecast, by Stage
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Application
      • 16.3.16.4 Switzerland Market Size and Forecast, by End User
      • 16.3.16.5 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.6 Switzerland Market Size and Forecast, by Form
      • 16.3.16.7 Switzerland Market Size and Forecast, by Services
      • 16.3.16.8 Switzerland Market Size and Forecast, by Mode
      • 16.3.16.9 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Application
      • 16.3.17.4 Denmark Market Size and Forecast, by End User
      • 16.3.17.5 Denmark Market Size and Forecast, by Technology
      • 16.3.17.6 Denmark Market Size and Forecast, by Form
      • 16.3.17.7 Denmark Market Size and Forecast, by Services
      • 16.3.17.8 Denmark Market Size and Forecast, by Mode
      • 16.3.17.9 Denmark Market Size and Forecast, by Stage
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Application
      • 16.3.18.4 Finland Market Size and Forecast, by End User
      • 16.3.18.5 Finland Market Size and Forecast, by Technology
      • 16.3.18.6 Finland Market Size and Forecast, by Form
      • 16.3.18.7 Finland Market Size and Forecast, by Services
      • 16.3.18.8 Finland Market Size and Forecast, by Mode
      • 16.3.18.9 Finland Market Size and Forecast, by Stage
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Application
      • 16.3.19.4 Russia Market Size and Forecast, by End User
      • 16.3.19.5 Russia Market Size and Forecast, by Technology
      • 16.3.19.6 Russia Market Size and Forecast, by Form
      • 16.3.19.7 Russia Market Size and Forecast, by Services
      • 16.3.19.8 Russia Market Size and Forecast, by Mode
      • 16.3.19.9 Russia Market Size and Forecast, by Stage
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Form
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Mode
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.5 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Form
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Mode
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Application
      • 16.4.9.4 China Market Size and Forecast, by End User
      • 16.4.9.5 China Market Size and Forecast, by Technology
      • 16.4.9.6 China Market Size and Forecast, by Form
      • 16.4.9.7 China Market Size and Forecast, by Services
      • 16.4.9.8 China Market Size and Forecast, by Mode
      • 16.4.9.9 China Market Size and Forecast, by Stage
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Application
      • 16.4.10.4 India Market Size and Forecast, by End User
      • 16.4.10.5 India Market Size and Forecast, by Technology
      • 16.4.10.6 India Market Size and Forecast, by Form
      • 16.4.10.7 India Market Size and Forecast, by Services
      • 16.4.10.8 India Market Size and Forecast, by Mode
      • 16.4.10.9 India Market Size and Forecast, by Stage
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Application
      • 16.4.11.4 Japan Market Size and Forecast, by End User
      • 16.4.11.5 Japan Market Size and Forecast, by Technology
      • 16.4.11.6 Japan Market Size and Forecast, by Form
      • 16.4.11.7 Japan Market Size and Forecast, by Services
      • 16.4.11.8 Japan Market Size and Forecast, by Mode
      • 16.4.11.9 Japan Market Size and Forecast, by Stage
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Application
      • 16.4.12.4 South Korea Market Size and Forecast, by End User
      • 16.4.12.5 South Korea Market Size and Forecast, by Technology
      • 16.4.12.6 South Korea Market Size and Forecast, by Form
      • 16.4.12.7 South Korea Market Size and Forecast, by Services
      • 16.4.12.8 South Korea Market Size and Forecast, by Mode
      • 16.4.12.9 South Korea Market Size and Forecast, by Stage
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Application
      • 16.4.13.4 Australia Market Size and Forecast, by End User
      • 16.4.13.5 Australia Market Size and Forecast, by Technology
      • 16.4.13.6 Australia Market Size and Forecast, by Form
      • 16.4.13.7 Australia Market Size and Forecast, by Services
      • 16.4.13.8 Australia Market Size and Forecast, by Mode
      • 16.4.13.9 Australia Market Size and Forecast, by Stage
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Application
      • 16.4.14.4 Singapore Market Size and Forecast, by End User
      • 16.4.14.5 Singapore Market Size and Forecast, by Technology
      • 16.4.14.6 Singapore Market Size and Forecast, by Form
      • 16.4.14.7 Singapore Market Size and Forecast, by Services
      • 16.4.14.8 Singapore Market Size and Forecast, by Mode
      • 16.4.14.9 Singapore Market Size and Forecast, by Stage
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Application
      • 16.4.15.4 Indonesia Market Size and Forecast, by End User
      • 16.4.15.5 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.6 Indonesia Market Size and Forecast, by Form
      • 16.4.15.7 Indonesia Market Size and Forecast, by Services
      • 16.4.15.8 Indonesia Market Size and Forecast, by Mode
      • 16.4.15.9 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Application
      • 16.4.16.4 Taiwan Market Size and Forecast, by End User
      • 16.4.16.5 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.6 Taiwan Market Size and Forecast, by Form
      • 16.4.16.7 Taiwan Market Size and Forecast, by Services
      • 16.4.16.8 Taiwan Market Size and Forecast, by Mode
      • 16.4.16.9 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Application
      • 16.4.17.4 Malaysia Market Size and Forecast, by End User
      • 16.4.17.5 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.6 Malaysia Market Size and Forecast, by Form
      • 16.4.17.7 Malaysia Market Size and Forecast, by Services
      • 16.4.17.8 Malaysia Market Size and Forecast, by Mode
      • 16.4.17.9 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Application
    • 16.5.5 Latin America Market Size and Forecast, by End User
    • 16.5.6 Latin America Market Size and Forecast, by Technology
    • 16.5.7 Latin America Market Size and Forecast, by Form
    • 16.5.8 Latin America Market Size and Forecast, by Services
    • 16.5.9 Latin America Market Size and Forecast, by Mode
    • 16.5.10 Latin America Market Size and Forecast, by Stage
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Application
      • 16.5.9.4 Brazil Market Size and Forecast, by End User
      • 16.5.9.5 Brazil Market Size and Forecast, by Technology
      • 16.5.9.6 Brazil Market Size and Forecast, by Form
      • 16.5.9.7 Brazil Market Size and Forecast, by Services
      • 16.5.9.8 Brazil Market Size and Forecast, by Mode
      • 16.5.9.9 Brazil Market Size and Forecast, by Stage
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Application
      • 16.5.10.4 Mexico Market Size and Forecast, by End User
      • 16.5.10.5 Mexico Market Size and Forecast, by Technology
      • 16.5.10.6 Mexico Market Size and Forecast, by Form
      • 16.5.10.7 Mexico Market Size and Forecast, by Services
      • 16.5.10.8 Mexico Market Size and Forecast, by Mode
      • 16.5.10.9 Mexico Market Size and Forecast, by Stage
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Application
      • 16.5.11.4 Argentina Market Size and Forecast, by End User
      • 16.5.11.5 Argentina Market Size and Forecast, by Technology
      • 16.5.11.6 Argentina Market Size and Forecast, by Form
      • 16.5.11.7 Argentina Market Size and Forecast, by Services
      • 16.5.11.8 Argentina Market Size and Forecast, by Mode
      • 16.5.11.9 Argentina Market Size and Forecast, by Stage
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Form
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Mode
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.5 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Form
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Mode
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Form
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Mode
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Application
      • 16.6.10.4 UAE Market Size and Forecast, by End User
      • 16.6.10.5 UAE Market Size and Forecast, by Technology
      • 16.6.10.6 UAE Market Size and Forecast, by Form
      • 16.6.10.7 UAE Market Size and Forecast, by Services
      • 16.6.10.8 UAE Market Size and Forecast, by Mode
      • 16.6.10.9 UAE Market Size and Forecast, by Stage
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Application
      • 16.6.11.4 South Africa Market Size and Forecast, by End User
      • 16.6.11.5 South Africa Market Size and Forecast, by Technology
      • 16.6.11.6 South Africa Market Size and Forecast, by Form
      • 16.6.11.7 South Africa Market Size and Forecast, by Services
      • 16.6.11.8 South Africa Market Size and Forecast, by Mode
      • 16.6.11.9 South Africa Market Size and Forecast, by Stage
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Form
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Mode
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Advanced Accelerator Applications
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Blue Earth Diagnostics
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 ITM Isotope Technologies Munich
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Lantheus Medical Imaging
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Jubilant Radiopharma
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Curium
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Telix Pharmaceuticals
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Bayer Radiopharma
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 NorthStar Medical Radioisotopes
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Eckert & Ziegler
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Sofie Biosciences
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Cardinal Health Radiopharmacy
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Isotopia Molecular Imaging
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Radiomedix
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 ImaginAb
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis